Saturday

17th Apr 2021

Doubts over EU chemical agency after weedkiller study

  • Last year saw important public resistance to glyphosate. (Photo: Moritz Richter/Campact)

Green MEPs and health and environment NGOs said the European Chemicals Agency (Echa) could be suffering from lack of transparency.

The criticism came after the Helsinki-based agency said earlier that day that there wasn't sufficient scientific evidence to classify glyphosate as a carcinogen.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

Echa's assessment, which was published on Wednesday (15 March) had been long-awaited.

Many people believe glyphosate, the world’s most widely-used weed-killing substance, causes cancer.

A substantial public campaign last year urged EU governments and the European Commission not to renew the marketing authorisation for glyphosate, after it expired last June.

EU governments failed time and time again to agree on the matter in the so-called comitology procedure, where their scientific experts are represented. The decision eventually landed with the commission, which suggested to temporarily extend the marketing permit by 18 months while waiting for Echa's opinion.

The European Parliament's Green group said Echa's opinion "doesn't answer all the questions on glyphosate".

Troubling transparency

A group of Green MEPs have asked for industry studies on glyphosate, in order to make their own scientific assessment. The MEPs have to date only received a partial reply, with heavily redacted studies.

Greens/EFA transparency spokesperson Benedek Javor said: “Today’s decision demonstrates again why we need greater transparency on the studies used to judge glyphosate’s safety.

"This controversy will continue, and citizens will continue to have understandable doubts regarding the safety of glyphosate, until the studies used are made public," he added.

The Health and Environment Alliance (Heal) said on Wednesday that Echa's opinion contradicts that of the gold standard of cancer evaluation - the World Health Organisation’s International Agency for Research on Cancer (IARC) - which classified glyphosate as a "probable carcinogen" in 2015.

Heal said the contradiction "feeds public suspicion about the reliability of EU scientific agencies’ opinions" and that there was "growing unease exists about the lack of transparency in the classification process of the European agencies".

Greenpeace, Heal and many other groups sent a letter last week to the commission, saying that Echa was using “unpublished scientific evidence provided by industry in formulating its opinions”, in addition to studies published in peer-reviewed journals.

The letter also expressed concerns about the conflicts of interest of some of the members of the Echa expert committee, and asked the health commissioner, Vytenis Andriukaitis, to "enforce and improve Echa's policies to safeguard its independence from industry and transparency of its work".

Andriukaitis himself suggested that some kind of reform might be needed, according to the meeting minutes from a European Commission college meeting in February.

According to the minutes, the health commissioner felt that "in certain publicly controversial cases within his portfolio, member states were tempted to evade their responsibilities … by leaving the commission to take unpopular decisions alone".

Lack of confidence

The Lithuanian lawmaker, who is a heart surgeon by profession, added that "the main problem was the public's lack of confidence in science and the feeling that Europe was not sufficiently protecting them from the effects of certain chemical substances."

The commission last month unveiled a proposal for comitology reforms, in a bid to have member states share the flak for controversial decisions.

But Andriukaitis felt that that there was also a need for “a reform of the EU agencies responsible for providing the scientific basis for these decisions and of their procedures, to make them more transparent”.

The commission will re-start discussions with member states as regards the approval of glyphosate in a few months, after it receives Echa's opinion, which first has to go through an editorial check.

A commission spokesman told EUobserver he expected a decision to be taken within six months of receipt of Echa's opinion, or by the end of 2017 at the latest.

Echa said it had full access to published, peer-reviewed studies on glyphosate, as well as industry reports. It also used any scientifically relevant information received during a public consultation in summer 2016.

The European Crop Protection Association (Ecpa), the umbrella organisation for pest control companies, welcomed the assessment.

Ecpa spokesman Graeme Taylor said: "Science prevailed."

"We expect the European Commission to move swiftly with the registration process for the substance in the EU and grant a 15-year approval – the same approval that was originally suggested by the EC before the substance became the subject of a political and emotional debate rather than a scientific one," he added.

EU declines to renew glyphosate licence

Member states did not agree on conditions to renew the permit for the chemical used in pesticides, amid contradictory evidence on a possible cancer link.

EU fails to reach weed-killer deal, again

Painful process to agree on use of glyphosate, a weed-killing chemical linked to a cancer scare, could end up with EU Commission taking unilateral action.

Brussels wants EU states to share flak for GMO approvals

European Commission proposes changes to the little-known but often used comitology procedure, which results in deadlocks whenever controversial issues like genetically modified organisms are on the table.

News in Brief

  1. EU postpones decision on labelling gas 'sustainable'
  2. MEPs call for mass surveillance ban in EU public spaces
  3. Greek and Turkish ministers trade jibes in Ankara
  4. Biden repeats opposition to Russia-Germany pipeline
  5. Navalny in danger, letter warns EU foreign ministers
  6. Lithuania keen to use Denmark's AstraZeneca vaccines
  7. Gas plants largest source of power-sector emissions
  8. Study: Higher risk of blood clots from Covid than vaccines

EU faces long wait for full vaccine supplies

The EU is still several months away from having enough vaccines to inoculate its 450 million people, with Pfizer and BioNTech, its principle suppliers, aiming for September for delivery targets.

Stakeholders' Highlights

  1. Nordic Council of MinistersDigitalisation can help us pick up the green pace
  2. Nordic Council of MinistersCOVID19 is a wake-up call in the fight against antibiotic resistance
  3. Nordic Council of MinistersThe Nordic Region can and should play a leading role in Europe’s digital development
  4. Nordic Council of MinistersNordic Council to host EU webinars on energy, digitalisation and antibiotic resistance
  5. UNESDAEU Code of Conduct can showcase PPPs delivering healthier more sustainable society
  6. Nordic Council of MinistersWomen benefit in the digitalised labour market

Latest News

  1. US rejects Slovenia-linked plan to break up Bosnia
  2. Ukraine urges Borrell to visit Russia front line
  3. Could US sanctions hit Russia vaccine sales to EU?
  4. Polish court pushes out critical ombudsman
  5. Political crises in Romania and Bulgaria amid third wave
  6. Von der Leyen's summer plans undisclosed, after Ukraine snub
  7. Over a million EU citizens back farm-animal cage ban
  8. Three options for West on Putin's Ukraine build-up

Join EUobserver

Support quality EU news

Join us